New hope for brain cancer: drug cocktail targets tough lymphoma
Disease control
Recruiting now
This study tests a new three-drug combination (selinexor, methotrexate, and rituximab) for adults with central nervous system lymphoma that has returned or not responded to prior treatment. About 30 participants will receive the drugs to find the safest dose and see how well it s…
Phase: PHASE1, PHASE2 • Sponsor: Tong Chen, MD • Aim: Disease control
Last updated May 17, 2026 05:37 UTC